Form 4 for CBIO CRESCENT BIOPHARMA, INC.
Accepted 2023-05-18 00:00:00 ET · period of report 2023-05-17 · accession 0001209191-23-030636 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-18 | 2023-05-17 | CBIO | Hahn Brian M. | CFO, SVP Fin | S - Sale | $1.95 | -3,700 | 53.1K | -7% | -$7,215 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-17 | S | D | 3,700 | $1.95 | 53,143 | D | — | — |